Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study
Articolo
Data di Pubblicazione:
2022
Citazione:
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study / Gandaglia, Giorgio; Mazzone, Elio; Stabile, Armando; Pellegrino, Antony; Cucchiara, Vito; Barletta, Francesco; Scuderi, Simone; Robesti, Daniele; Leni, Riccardo; Samanes Gajate, Ana Maria; Picchio, Maria; Gianolli, Luigi; Brembilla, Giorgio; De Cobelli, Francesco; Van Oosterom, Matthias N; Van Leeuwen, Fijs W B; Montorsi, Francesco; Briganti, Alberto. - In: EUROPEAN UROLOGY. - ISSN 1873-7560. - 82:4(2022), pp. 411-418. [10.1016/j.eururo.2022.06.002]
Abstract:
Extended pelvic nodal dissection (ePLND) represents the gold standard for nodal staging in prostate cancer (PCa). Prostate-specific membrane antigen (PSMA) radioguided surgery (RGS) could identify lymph node invasion (LNI) during robot-assisted radical prostatectomy (RARP).
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Gandaglia, Giorgio; Mazzone, Elio; Stabile, Armando; Pellegrino, Antony; Cucchiara, Vito; Barletta, Francesco; Scuderi, Simone; Robesti, Daniele; Leni, Riccardo; Samanes Gajate, Ana Maria; Picchio, Maria; Gianolli, Luigi; Brembilla, Giorgio; De Cobelli, Francesco; Van Oosterom, Matthias N; Van Leeuwen, Fijs W B; Montorsi, Francesco; Briganti, Alberto
Link alla scheda completa:
Link al Full Text:
Pubblicato in: